Synthon Pharmaceuticals, Inc.

Synthon Pharmaceuticals, Inc. (Synthon Pharmaceuticals) is a privately held biotechnology company and is engaged in development, registration, production, marketing and distribution of a wide range of generic pharmaceutical products. The company lays its focus on the chemical development and production of active substances to the pharmaceutical development, manufacturing and packaging of finished dosage forms. Synthon Pharmaceuticals markets generic drugs under its own name and through partnerships with other leading pharmaceutical companies. Currently, the company owns several approved, or tentatively approved, drug applications under its pipeline. Recently, it received the final US FDA approval for its Abbreviated New Drug Application (ANDA) for tamsulosin hydrochloride capsules. Synthon Pharmaceuticals is headquartered at Research Triangle Park in North Carolina, the US.